Mark PlavsicPhD, MS, Dsc
Mark is responsible for Lysogene’ s manufacturing strategy and CMC operational development. He has extensive technical experience across a diverse range of functions, proven knowledge of quality compliance and regulatory requirements and strong business and leadership skills gained from over 30 years of experience working in North America, Europe and Australasia. Prior to joining Lysogene, Mark worked as Head of Process Development and Manufacturing at Torque Therapeutics, leading multiple functions including process and analytics development and ensuring quality controls and design across manufacturing.
Prior to that, Dr. Plavsic held multiple positions with Sanofi Genzyme, Astra Zeneca and Invitrogen Corporation. Dr. Plavsic received his Ph.D in Virology and Molecular Cell Biology, M.S. in Virology and Immunology, and Doctor of Veterinary Medicine degree from the University of Belgrade in Yugoslavia. He has a Board certification in Microbiology, subspecialty Virology from the American College of Veterinary Microbiologists.